Clinical Trial Update: The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the HepQuant SHUNT test in monitoring liver disease (NASH) and treatment effects; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• HepQuant SHUNT test

Snippet

Sponsor: HepQuant, LLC | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: TERMINATED | Results posted: 2021-07-15